Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: A 6 year single institutional experience

Clinical Neurology and Neurosurgery

Volumn 115, Issue 9, 2013, Pages 1609-1614

  Ciammella, Patrizia ^a   Galeandro, Maria ^a   D'Abbiero, Nunziata ^a   Podgornii, Ala ^a   Pisanello, Anna ^b   Botti, Andrea ^b   Cagni, Elisabetta ^b   Iori, Mauro ^b   Iotti, Cinzia ^a  

^a Santa Maria Nuova Istituto di Ricovero e Cura A Carattere Scientifico Hospital   (Italy)

^b Rheumatology Unit   (Italy)

Author keywords

Glioblastoma; Hypofractionated radiation therapy; Temozolomide

Indexed keywords

DEXAMETHASONE; GADOLINIUM; TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COGNITIVE DEFECT; CONFUSION; DRUG DOSE REDUCTION; FATIGUE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEADACHE; HUMAN; INSOMNIA; INTENSITY MODULATED RADIATION THERAPY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; RADIATION DOSE; RECURRENT CANCER; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR BIOPSY; WEAKNESS;

GLIOBLASTOMA; HYPOFRACTIONATED RADIATION THERAPY; TEMOZOLOMIDE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DACARBAZINE; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84887619741     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2013.02.001     Document Type: Article

References (40)

1. J. Welsh, A. Sanan, A.J. Gabayan, S.B. Green, R. Lustig, and S. Burri GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study International Journal of Radiation Oncology, Biology, Physics 68 1 2007 159 165 [Epub 2007 February 27]
2. V. Panet-Raymond, L. Souhami, D. Roberge, P. Kavan, L. Shakibnia, and T. Muanza Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis International Journal of Radiation Oncology, Biology, Physics 73 2 2009 473 478 [Epub 2008 June 12]
3. L. Souhami, W. Seiferheld, D. Brachman, E.B. Podgorsak, M. Werner-Wasik, and R. Lustig Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol International Journal of Radiation Oncology, Biology, Physics 60 3 2004 853 860
4. R. Cardinale, M. Won, A. Choucair, M. Gillin, A. Chakravarti, and C. Schultz A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023 International Journal of Radiation Oncology, Biology, Physics 65 5 2006 1422 1428 [Epub 2006 June 5]
5. N.J. Laperriere, P.M. Leung, S. McKenzie, M. Milosevic, S. Wong, and J. Glen Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma International Journal of Radiation Oncology, Biology, Physics 41 5 1998 1005 1011
6. C. Nieder, N. Andratschke, N. Wiedenmann, R. Busch, A.L. Grosu, and M. Molls Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome Strahlentherapie und Onkologie 180 7 2004 401 407 [Review]
7. G.G. Grabenbauer, K.D. Gerber, O. Ganslandt, A. Richter, G. Klautke, and J. Birkmann Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme International Journal of Radiation Oncology, Biology, Physics 75 1 2009 164 169
8. H. Colman, B.A. Berkey, M.H. Maor, M.D. Groves, C.J. Schultz, and S. Vermeulen Radiation Therapy Oncology Group: Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710 International Journal of Radiation Oncology, Biology, Physics 66 3 2006 818 824 [Epub 2006 August 2]
9. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, and M.J. Taphoorn Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma New England Journal of Medicine 352 2005 987 996
10. R.C. Krempien, K. Schubert, D. Zierhut, M.C. Steckner, M. Treiber, and W. Harms Open low-field magnetic resonance imaging in radiation therapy treatment planning International Journal of Radiation Oncology, Biology, Physics 53 2002 1350 1360
11. A.F. Thornton Jr., H.M. Sandler, R.K. Ten Haken, D.L. McShan, B.A. Fraass, and M.L. La Vigne The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms International Journal of Radiation Oncology, Biology, Physics 24 1992 767 775
12. M. Just, H.P. Rösler, H.P. Higer, J. Kutzner, and M. Thelen MRI-assisted radiation therapy planning of brain tumors clinical experiences in 17 patients Magnetic Resonance Imaging 9 1991 173 177
13. T. Gupta, and K. Dinshaw Modified optimal fractionation for poor prognosis malignant gliomas: an elusive search Acta Oncologica 44 2005 105 113
14. L.M. Garcia, D.E. Wilkins, and Raaphorst GP Alpha/beta ratio: a dose range dependance study International Journal of Radiation Oncology, Biology, Physics 67 2007 587 593
15. B. Glinski Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas: a preliminary report on a randomised trial Journal of Neuro-Oncology 26 1993 167 172
16. C. Phillips, M. Guiney, J. Smith, P. Hughes, K. Narayan, and G. Quong A randomized trial comparing 35 Gy in 10 fractions with 60 Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma Radiotherapy and Oncology 68 2003 23 26
17. W. Roa, P.M. Brasher, G. Bauman, M. Anthes, E. Bruera, and A. Chan Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial Journal of Clinical Oncology 22 2004 1583 1588
18. G. Minniti, V. De Sanctis, R. Muni, D. Rasio, G. Lanzetta, and M.F. Osti Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma Journal of Neuro-Oncology 91 2009 95 100
19. M. Teresaki, T. Eto, S. Nakashima, Y. Okada, E. Ogo, and Y. Sugita A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme Journal of Neuro-Oncology 102 2011 247 253
20. C. Chen, D. Damek, L.E. Gaspar, A. Waziri, K. Lillehei, and B.K. Kleinschmidt-DeMasters Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme International Journal of Radiation Oncology, Biology, Physics 81 2011 1066 1074
21. J. Cao, B. Fisher, G. Bauman, and J. Megyesi Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience Journal of Neuro-Oncology 107 2012 395 405
22. K. Reddy, D. Damek, L. Gaspar, D. Ney, A. Waziri, and K. Lillehei Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme International Journal of Radiation Oncology, Biology, Physics 2012 1 6
23. M. Iori, M. Paiusco, E. Cagni, S. Riccardi, D. Lambertini, and N. Bizzocchi The intensity modulated multiple arc (IMMA) technique: forward & inverse planned procedures to deliver hypo-fractionated IMAT treatments Current Radiopharmaceuticals 2 2009 1 11
24. M. Iori, E. Cagni, A.E. Nahum, and G. Borasi IMAT-SIM: a new method for the clinical dosimetry of intensity-modulated arc therapy (IMAT) Medical Physics 34 2007 2759 2773
25. D.R. MacDonald, T.L. Cascino, S.C. Schold Jr., and Cairncross JG Response criteria for phase II studies of supratentorial malignant glioma Journal of Clinical Oncology 8 1990 1277 1280
26. S.W. Lee, B.A. Fraass, L.H. Marsh, K. Herbort, S.S. Gebarski, and M.K. Martel Patterns of failure following hig-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study International Journal of Radiation Oncology, Biology, Physics 43 1999 79 88
27. K. Nakagawa, Y. Aoki, T. Fujimaki, M. Tago, A. Terahara, and K. Karasawa High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in gioblastoma multiforme International Journal of Radiation Oncology, Biology, Physics 40 1998 1141 1149
28. J.L. Chan, S.W. Lee, B.A. Fraass, D.P. Normolle, H.S. Greenberg, and L.R. Junck Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy Journal of Clinical Oncology 20 2002 1635 1642
29. L. Kleinberg, T. Slick, C. Enger, S. Grossman, H. Brem, and M.D. Wharam Jr. Short course radiotherapy is an appropriate option for most malignant glioma patients International Journal of Radiation Oncology, Biology, Physics 38 1997 31 36
30. B.J. Slotman, J.H. Kralendok, H.A. van Alphen, W. Kamphorst, and A.B. Karim Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors International Journal of Radiation Oncology, Biology, Physics 34 1996 895 898
31. G. Filippini, C. Falcone, A. Boiardi, G. Broggi, M.G. Bruzzone, and D. Caldiroli Prog-nostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma Neuro-Oncology 10 2008 79 87
32. J. Lutterbach, W. Sauerbrei, and R. Guttenberger Multivariate analysis of prognostic factors in patients with glioblastoma Strahlentherapie Und Onkologie 179 2003 8 15
33. M. Lacroix, D. Abi-Said, D.R. Fourney, Z.L. Gokaslan, W. Shi, and F. DeMonte A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival Journal of Neurosurgery 95 2001 190 198
34. G. Filippini, C. Falcone, A. Boiardi, G. Broggi, M.G. Bruzzone, and D. Caldiroli Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma Neuro-Oncology 10 2008 79 87
35. J. Lutterbach, W. Saurbrei, and R. Guttenberger Multivariate analysis of prognostic factors in patients with glioblastoma Strahlentherapie Und Onkologie 179 2003 8 15
36. M. Lacroix, D. Abi-Said, D.R. Fourney, Z.L. Gokaslan, W. Shi, and F. DeMonte A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival Journal of Neurosurgery 95 2011 190 198
37. R. Stupp, M.E. Hegi, W.P. Mason, M.J. van den Bent, M.J. Taphoorn, and R.C. Janzer Effects of radiotherapy with concomitant and adjuvant TMZ versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncology 10 2009 459 466
38. S.R. Floyd, E.M. Kasper, E.J. Uhlmann, E. Fonkem, E.T. Wong, and A. Mahadevan Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolamide for glioblastoma in good performance status elderly patients-early results of a phase II trial Frontiers in Oncology 2 2012 122
39. A. Malmström, B.H. Grønberg, C. Marosi, R. Stupp, D. Frappaz, and H. Schultz Nordic Clinical Brain Tumour Study Group (NCBTSG) Lancet Oncology 13 September (9) 2012 916 926
40. M. Hingorani, W.P. Colley, S. Dixit, and A.M. Beavis Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future? British Journal of Radiology 85 September (1017) 2012 e770 e781 10.1259/bjr/83827377 [Review]